Source: Eur Respir J 2011; 37: 465



Rating:

Share or cite this content

Citations should be made in the following way:
Ishii H., Tazawa R., Kaneko C., Saraya T., Inoue Y., Hamano E., Kogure Y., Tomii K., Terada M., Takada T., Hojo M., Nishida A., Ichiwata T., Trapnell B.C., Goto H., Nakata K.. Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan. Eur Respir J 2011; 37: 465

Member's Comments

No comment yet.

Related content which might interest you: Clinical and paraclinical manifestations of pulmonary alveolar proteinosis in children Source: Eur Respir J 2007; 30: Suppl. 51, 402s Year: 2007 Clinical characteristics of pulmonary alveolar microlithiasis in Japan Source: Eur Respir J 2004; 24: Suppl. 48, 670s Year: 2004 Fatal cases of pulmonary alveolar proteinosis: a nationwide surveillance in Japan Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018 Pulmonary alveolar proteinosis: report of two cases Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Our cases with pulmonary alveolar proteinosis Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 Pulmonary alveolar proteinosis (PAP) - clinical features and response to treatment by bronchofiberoscopic lobar lavage Source: Eur Respir J 2005; 26: Suppl. 49, 541s Year: 2005 Alveolar proteinosis: epidemiology, possibilities of diagnosis Source: Eur Respir J 2004; 24: Suppl. 48, 671s Year: 2004 Clinical assessment and management of pulmonary alveolar proteinosis: the importance of a reference centre Source: Annual Congress 2009 - Pulmonary alveolar proteinosis: clearing the Milky Way Year: 2009 Pulmonary alveolar proteinosis: from classification to therapy Source: Breathe, 16 (2) 200018; 10.1183/20734735.0018-2020 Year: 2020 LATE-BREAKING ABSTRACT: Clinical features common to five cases with secondary pulmonary alveolar proteinosis complicated with Behcet disease Source: Annual Congress 2012 - Interstitial lung disease: from bench to bedside Year: 2012 Pulmonary alveolar proteinosis, study of 29 cases Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 Pulmonary alveolar proteinosis and GMSCF antibodies: a case series Source: Eur Respir J 2004; 24: Suppl. 48, 670s Year: 2004 Autoimmune pulmonary alveolar proteinosis complicated with infections: a nationwide surveillance study in Japan Source: International Congress 2017 – Rare diseases Year: 2017 Lung cysts in pulmonary alveolar proteinosis. Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 Pulmonary alveolar proteinosis and idiopathic pulmonary hemosiderosis Source: International Congress 2019 – CCC Airway diseases Year: 2019 Long clinical course of pulmonary alveolar microlithiasis in Japan Source: Eur Respir J 2003; 22: Suppl. 45, 198s Year: 2003 Comorbid interstitial lung diseases and collagen vascular diseases in pulmonary alveolar proteinosis: a nationwide surveillance in Japan Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Possible ocular involvement in pulmonary alveolar proteinosis Source: Eur Respir J 2006; 28: 456 Year: 2006